The proform of eosinophil major basic protein: A new maternal serum marker for Down syndrome

Prenatal Diagnosis

Volumn 19, Issue 10, 1999, Pages 905-910

  Christiansen, Michael ^a   Oxvig, Claus ^b   Wagner, Jill M ^c   Qin, Qiu Ping ^a   Nguyen, Tri H ^a   Overgaard, Michael T ^b   Larsen, Severin O ^a   Sottrup Jensen, Lars ^b   Gleich, Gerald J ^c   Nørgaard Pedersen, Bent ^a  

^a STATENS SERUM INSTITUT   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c MAYO CLINIC   (United States)

Author keywords

Down syndrome; Eosinophil major basic protein; First trimester; Prenatal screening; Receiver operator characteristics; Second trimester

Indexed keywords

ALPHA FETOPROTEIN; BIOLOGICAL MARKER; CHORIONIC GONADOTROPIN; ESTRIOL; MAJOR BASIC PROTEIN;

ADULT; ARTICLE; BLOOD LEVEL; COMPARATIVE STUDY; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DOWN SYNDROME; FEMALE; FETUS MALFORMATION; FIRST TRIMESTER PREGNANCY; GESTATIONAL AGE; HUMAN; HUMAN CELL; MAJOR CLINICAL STUDY; MATERNAL SERUM; PRENATAL SCREENING; PRIORITY JOURNAL; SECOND TRIMESTER PREGNANCY; STATISTICAL ANALYSIS;

EID: 0032832077     PISSN: 01973851     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0223(199910)19:10<905::AID-PD658>3.0.CO;2-Q     Document Type: Article

References (48)

1. Altman DG. 1991. Practical Statistics for Medical Research, 1st edn. London: Chapman & Hall.
2. Barker RL, Gleich GJ, Pease LR. 1988. Acidic precursor revealed in human eosinophil granule major basic protein cDNA. J Exp Med 168: 1493-1498.
3. Bersinger NA, Marquerat P, Pescia G, Schneider H. 1995. Pregnancy-associated plasma protein A (PAPP-A): measurement by highly sensitive and specific enzyme immunoassay, importance of first-trimester serum determinations and stability studies. Reprod Fertil Dev 7: 1419-1423.
4. Bonno M, Oxvig C, Kephart GM, Wagner JM, Kristensen T, Sottrup-Jensen L, Gleich GJ. 1994a. Localization of pregnancy-associated plasma protein-A and colocalization of pregnancy-associated plasma protein-A messenger ribonucleic acid and eosinophil granule major basic protein messenger ribonucleic acid in placenta. Lab Invest 71: 560-566.
5. Bonno M, Kephart GM, Carlson CM, Loegering DA, Vernof KK, Gleich GJ. 1994b. Expression of eosinophil-granule major basic protein messenger ribonucleic acid in placental X cells. Lab Invest 70: 234-241.
6. Brambati B, Tului L, Bonacchi I, Shrimanker K, Suzuki Y, Grudzinskas JG. 1994. Serum PAPP-A, free β-hCG are first-trimester screening markers for Down syndrome. Prenat Diagn 14: 1043-1047.
7. Casals E, Fortuny A, Grudzinskas JG, Suzuki Y, Teisner B, Comas C, Sanllehy C, Ojuel J, Borrell A, Soler A, Ballestra AM. 1996. First-trimester biochemical screening for Down syndrome with the use of PAPP-A, AFP and β-hCG. Prenat Diagn 16: 405-410.
8. Cuckle HS, Wald NJ, Thompson SG. 1987. Estimating a woman's risk of having a pregnancy associated with Down's syndrome using her age and serum alpha-fetoprotein level. Br J Obstet Gynaecol 94: 387-402.
9. Danmarks Statistik 1993. Danish Statistical Yearbook 1992. Danmarks Statistik: Copenhagen.
10. Dempsey PW, Allison MED, Akkaraju S, Goodnow CC, Fearon DT. 1996. C3d of complement as a molecular adjuvant: bridging innate and acquired immunity. Science 271: 348-350.
11. Firth HV, Boyd PA, Chamberlain PF, Mackenzie IZ, Morriss-Kay GM, Huson SM. 1994. Analysis of limb reduction defects in babies exposed to chorionic villus sampling. Lancet 343: 1069-1071.
12. Forest JC, Masse J, Moutquin JM. 1997. Screening for Down syndrome during first trimester: a prospective study using free beta-human chorionic gonadotropin and pregnancy-associated plasma protein A. Clin Biochem 30: 333-338.
13. Gleich GJ, Adolphson CR. 1986. The eosinophilic leukocyte: structure and function. Adv Immunol 39: 177-253.
14. Hook EB, Cross PK, Jackson L, Pergament E. 1988. Maternal age specific rates of trisomy 21 and other cytogenetic abnormalities diagnosed in the first trimester of pregnancy in chorionic villus biopsy specimens: comparison with rates expected from observations at amniocentesis. Am J Hum Genet 42: 797-807.
15. Krantz DK, Larsen JW, Buchanan PD, Macri JN. 1996. First-trimester Down syndrome screening: free β-human chorionic gonadotrophin and pregnancy-associated plasma protein A. Am J Obstet Gynecol 174: 612-616.
16. Kratzer PG, Golbus MS, Schonberg SA, Heilbron DC, Taylor RN. 1992. Cytogenetic evidence for enhanced selective miscarriage of trisomy 21 pregnancies with advancing material age. Am J Med Genet 44: 657-663.
17. Kristensen T, Oxvig C, Sand O, Møller NPH, Sottrup-Jensen L. 1994. Amino acid sequence of human pregnancy-associated plasma protein-A derived from cloned cDNA. Biochemistry 33: 1592-1598.
18. Larsen SO, Christiansen M, Nørgaard-Pedersen B. 1998. Calculation of ROC curves in multidimensional likelihood ratio based screening with Down's syndrome as a special case. J Med Screen 5: 57-62.
19. Macintosh MCM, Iles R, Teisner B, Sharma K, Chard T, Grudzinskas JG, et al. 1994. Maternal serum human chorionic gonadotrophin and pregnacy-associated plasma protein A; markers for fetal Down syndrome at 8-14 weeks. Prenat Diagn 14: 203-208.
20. Macintosh MCM, Wald NJ, Chard T, Hansen J, Mikkelsen M, Therkelsen AJ, Petersen GB, Lundsteen C. 1995. Selective miscarriage of Down's syndrome fetuses in women aged 35 years and older. Br J Obstet Gynaecol 102: 798-801.
21. Maddox DE, Butterfield JH, Ackerman SJ, Coulam CB, Gleich GJ. 1983. Elevated serum levels in human pregnancy of a molecule immunochemically similar to eosinophil granule major basic protein. J Exp Med 158: 1211-1226.
22. Maddox DE, Kephart GM, Coulam CB, Butterfield JH, Benirschke K, Gleich GJ. 1984. Localization of a molecule immunochemically similar to eosinophil major basic protein in human placenta. J Exp Med 160: 29-41.
23. Muller F, Cuckle H, Teisner B, Grudzinskas JG. 1993. Serum PAPP-A levels are depressed in women with fetal Down syndrome in early pregnancy. Prenat Diagn 13: 633-636.
24. Oxvig C, Haaning J, Højrup P, Sottrup-Jensen L. 1994a. Location and nature of carbohydrate groups in proform of human major basic protein isolated from pregnancy serum. Biochem Mol Biol Int 33: 329-336.
25. Oxvig C, Haaning J, Kristensen L, Wagner JM, Rubin I, Stigbrand T, Gleich GJ, Sottrup-Jensen L. 1995. Identification of angiotensinogen and complement C3dg as novel proteins binding proform of major basic protein in human pregnancy serum and plasma. J Biol Chem 270: 13 645-13 651.
26. Oxvig C, Sand O, Kristensen T, Gleich GJ, Sottrup-Jensen L. 1993. Circulating human pregnancy-associated plasma protein-A is disulfide-bridged to the proform of eosinophil major basic protein. J Biol Chem 268: 12 243-12 246.
27. Oxvig C, Sand O, Kristensen T, Kristensen L, Sottrup-Jensen L. 1994b. Isolation and characterization of circulating complex between human pregnancy-associated plasma protein-A and proform of eosinophil major basic protein. Biochim Biophys Acta 1201: 415-423.
28. Pandya PP, Snijders RJM, Johnson SP, De Lourdes Brizot ?, Nicolaides KH. 1995. Screening for fetal trisomies by maternal age and fetal nuchal translucency thickness at 10 to 14 weeks of gestation. Br J Obstet Gynaecol 102: 957-962.
29. Paul M, Wagner J, Dzau VJ. 1992. Gene expression of the reninangiotensin system in human tissues. Quantitative analysis by the polymerase chain reaction. J Clin Invest 91: 2058-2064.
30. Popken-Harris P, McGrogan M, Loegering DA, Checkel JL, Kubo H, Thomas LL, Moy JN, Sottrup-Jensen L, Snable JL, Kikuchi MT, Gleich GJ. 1995. Expression, purification and characterization of the recombinant proform of eosinophil granule major basic protein. J Immunol 155: 1472-1480.
31. Qin QP, Christiansen M, Lovgren T, Norgaard-Pedersen B, Pettersson K. 1997a. Dual-label time-resolved immunofluorometric assay for simultaneous determination of pregnancy-associated plasma protein A and free beta-subunit of human chorionic gonadotrophin. J Immunol Meth 205: 169-175.
32. Qin QP, Christiansen M, Oxvig C, Pettersson K, Sottrup-Jensen L, Koch C, Nørgaard-Pedersen B, 1997b. Double-monoclonal immunofluorometric assays for pregnancy-associated plasma protein A/proeosinophil major basic protein (PAPP-A/proMBP) complex in first-trimester maternal serum screening for Down syndrome. Clin Chem 43: 2323-2332.
33. Qin QP, Christiansen M, Nguyen TH, Sørensen S, Larsen SO, Nørgaard-Pedersen B. 1997c. Schwangerschaftsprotein 1 (SP1) as maternal serum marker for Down Syndrome in first and second trimester. Prenat Diagn 17: 101-108.
34. Qin QP, Nguyen TH, Christiansen M, Larsen SO, Nørgaard-Pederson B. 1996. Time-resolved immunofluorometric assay of pregnancy-associated plasma protein A in maternal serum screening for Down's syndrome in first trimester of pregnancy. Clin Chim Acta 254: 113-127.
35. Royal College of Obstetricians and Gynaecologists (ROG) 1997. Chapter title. In: Grudzinskas JG, Ward RHT (eds) Screening for Down Syndrome in First Trimester. London: RCOG Press.
36. Snijders RJM, Holtzgreve W, Cuckle H, Nicolaides KH. 1994. Maternal age-specific risks for trisomies at 9-14 weeks' gestation. Prenat Diagn 14: 543-552.
37. Spencer K, Aitken DA, Crossley JA, McCaw G, Beny E, Anderson R, Connor JM, Macri JN. 1994. First trimester biochemical screening for trisomy 21: the role of free beta hCG, alpha-fetoprotein and pregnancy associated plasma protein A. Am Clin Biochem 31: 447-454.
38. Van der Veen WJ, Beekhuis JR, Cornel MC, Mantingh A, De Walle HEK, De Wolf BTHM. 1997. A demographic approach to the assessment of down syndrome screening performance. Prenat Diagn 17: 717-724.
39. Vernof KK, Benirschke K, Kephardt GM, Wasmoen TL, Gleich GJ. 1992a. Maternal floor infarction: relationship to X-cells, major basic protein and adverse perinatal outcome. Am J Obstet Gynecol 167: 1355-1363.
40. Vernof KK, Ory SJ, Gleich GJ. 1992b. Pregnancy-associated major basic protein in amniotic fluid. J Reprod Immunol 21: 47-56.
41. Wagner JM, Bartemes K, Vernof KK, Dunnette S, Offord KP, Checkel JL, Gleich GJ. 1993. Analysis of pregnancy-associated major basic protein levels throughout gestation. Placenta 14: 671-681.
42. Wald NJ, Densem JW, Smith D, Klee GG. 1994. Four-marker serum screening for Down's syndrome. Prenat Diagn 14: 707-716.
43. Wald NJ, George L, Smith D, Densem JW, Pettersson K. 1996. Serum screening for Down's syndrome between 8 and 14 weeks of pregnancy. Br J Obstet Gynaecol 103: 407-412.
44. Wald NJ, Kennard A, Hacksaw A, McGuire A. 1997. Antenatal screening for Down's syndrome. J Med Screen 4: 181-246.
45. Wald NJ, Stone R, Cuckle HS, Grudzinskas JG, Barki G, Brambati B, Teisner B, Fuhrman W. 1992. First trimester concentrations of pregnancy-associated plasma protein-A and placental protein 14 in Down's syndrome. BMJ 305: 28.
46. Wasmoen TL, Coulam CB, Benirschke K, Gleich GJ. 1991. Association of immunoreactive eosinophil major basic protein with placental septa and cysts. Am J Obstet Gynecol 165: 416-420.
47. Wasmoen TL, Coulam CB, Leiferman KM, Gleich GJ. 1987. Increases of plasma eosinophil major basic protein levels late in pregnancy predict onset of labor. Proc Natl Acad Sci U S A 84: 3029-3032.
48. Wasmoen TL, McKean DJ, Benirschke K, Coulam CB, Gleich GJ. 1989. Evidence of eosinophil granule major basic protein in human placenta. J Exp Med 170: 2051-2063.